New anticoagulant agents: direct thrombin inhibitors

Cardiology Clinics
Edith A NutescuAimee Chevalier

Abstract

Decades of research have been devoted to developing effective, safe, and convenient anticoagulant agents. In recent years, much emphasis has been placed on the development of direct thrombin inhibitors (DTIs) that offer benefits over agents like heparin and warfarin including the inhibition of both circulating and clot-bound thrombin; a more predictable anticoagulant response, because they do not bind to plasma proteins and are not neutralized by platelet factor 4; lack of required cofactors, such as antithrombin or heparin cofactor II; inhibiting thrombin-induced platelet aggregation; and absence of induction of immune-mediated thrombocytopenia. Various injectable DTIs are currently available and used for many indications. In addition, research is now focusing on oral DTIs that seem promising and offer various advantages, such as oral administration, predictable pharmacokinetics and pharmacodynamics, a broad therapeutic window, no routine monitoring, no significant drug interactions, and fixed-dose administration.

References

Sep 12, 1996·The New England Journal of Medicine·UNKNOWN Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
Apr 11, 2001·Circulation·B E LewisUNKNOWN ARG-911 Study Investigators
Feb 7, 2002·Lancet·UNKNOWN Direct Thrombin Inhibitor Trialists' Collaborative Group
Feb 14, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ulf G ErikssonDavid Gustafsson
May 14, 2003·European Journal of Clinical Pharmacology·Ulf G ErikssonDavid Gustafsson
Aug 13, 2003·Archives of Internal Medicine·Bruce E LewisUNKNOWN Argatroban-915 Investigators
Oct 28, 2003·Journal of Cardiothoracic and Vascular Anesthesia·George GordonWilliam Denman
Oct 31, 2003·The New England Journal of Medicine·Charles W FrancisUNKNOWN EXULT A Study Group
Oct 31, 2003·The New England Journal of Medicine·Sam SchulmanUNKNOWN THRIVE III Investigators
Jan 27, 2004·The Annals of Pharmacotherapy·Edith A Nutescu, Ann K Wittkowsky
Mar 18, 2004·Current Medical Research and Opinion·Kajs-Marie SchützerUlf G Eriksson
Jun 3, 2004·Best Practice & Research. Clinical Haematology·Theodore E Warkentin
Sep 21, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·Edith A Nutescu, Jerry L Bauman
Nov 6, 2004·The Journal of Cardiovascular Nursing·Edith A NutescuDorie W Schwertz
Nov 25, 2004·The Annals of Thoracic Surgery·Stephanie B ClaytonWalter E Uber
Jan 11, 2005·Hematology/oncology Clinics of North America·Eugene P FrenkelBarbara B Haley
Feb 11, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Michael J MannCharles Hoopes
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Jean-Noel FiessingerUNKNOWN THRIVE Treatment Study Investigators

❮ Previous
Next ❯

Citations

Aug 30, 2014·Clinics in Laboratory Medicine·C Cameron McCoyMark L Shapiro
Oct 22, 2013·American Journal of Surgery·Brian K YorkgitisJay E Dujon
Nov 26, 2013·Critical Care Nursing Clinics of North America·Katy M Toale
Jun 21, 2012·Critical Care Clinics·Anita RajasekharMark A Crowther
Jul 23, 2009·Toxicon : Official Journal of the International Society on Toxinology·Alexey V OsipovYuri N Utkin
Jan 19, 2011·British Journal of Clinical Pharmacology·Catherine J Lee, Jack E Ansell
Mar 2, 2011·Journal of Molecular Recognition : JMR·Helena C CastroCarlos R Rodrigues
May 28, 2016·Journal of the American College of Cardiology·Benjamin S SalterGregory W Fischer
Jul 12, 2016·Journal of Neuroimmunology·M Natalia MarangoniDouglas L Feinstein
Oct 23, 2010·Therapeutic Advances in Cardiovascular Disease·Mukesh SinghSandeep Khosla
May 5, 2011·The Annals of Pharmacotherapy·Jessica A BovioJohn G Gums
Oct 15, 2013·American Journal of Clinical Pathology·Anne M WinklerUNKNOWN Education Committee of the Academy of Clinical Laboratory Physicians and Scientists
Jun 25, 2009·Current Opinion in Hematology·Jennifer Carreiro Zikria, Jack Ansell
Jan 29, 2009·AACN Advanced Critical Care·Melanie L Sparks
May 16, 2009·Expert Opinion on Therapeutic Patents·A K Saha, D D'Cruz
Aug 13, 2009·Expert Review of Anticancer Therapy·Michaela J Higgins, Ben H Park
Oct 3, 2012·Critical Care Nurse·Nakia Merriweather, Linda M Sulzbach-Hoke
Feb 1, 2012·AACN Advanced Critical Care·Sudha Kurien, Kylie A Hughes
Oct 11, 2017·ACS Applied Materials & Interfaces·Jacques LuxRobert F Mattrey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.